Your gut health controls your immune system more than you think. Learn how an imbalanced gut can trigger autoimmunity and ...

Autoimmunity and Alzheimer’s. People with autoimmune disorders in the UCSF (left) and Stanford medical systems (right) were ...

Artiva Biotherapeutics' CEO Fred Aslan, MD, discusses two ongoing trials for autoimmunity indications in the US and how AlloNK differs from traditional B-cell depletion strategies.

Fate Therapeutics FATE reported a loss of 31 cents per share (excluding impairment loss) in the fourth quarter of 2024, narrower than the Zacks Consensus Estimate of a loss of 44 cents. The company ...

Q4 2024 Earnings Call Transcript March 12, 2025 Nektar Therapeutics misses on earnings expectations. Reported EPS is $-0.15 ...

CBS Colorado along with its partners, Chevron and Colorado School of Mines, honor high school students who excel in science, ...

Company is applying its T cell-selective lipid nanoparticle to develop siRNA therapeutics for T cell-driven autoimmune diseases- Lead target ...

Updates on ILYX-002 will be the focus of the upcoming Iolyx presentations, for which further details can be found below. Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting Date ...

Misdiagnosing autoimmune diseases as psychiatric conditions can lead to long-term damage to patients' health and trust in ...

Fate Therapeutics FATE reported a loss of 31 cents per share (excluding impairment loss) in the fourth quarter of 2024, narrower than the Zacks Consensus Estimate of a loss of 44 cents. The ...